However, in our study the beneficial effects of insulin degludec [19] and liraglutide [20], both associated with a reduced risk of dementia in frail, older adults with T2DM, may have been blunted in non-responders, potentially due to dysbiosis and/or drug resistance. This evidence concerns the gene INS and dementia.